MDB-78. ISOCITRATE DEHYDROGENASE 1 INHIBITION PRIMES GROUP-3 MEDULLOBLASTOMAS FOR CUPROPTOSIS
Derek Dang(University of Michigan), Sriram Venneti(University of Michigan), Matthew Pun(Duke University), Sunjong Ji(Michigan Medicine), Jennifer Cotter(Children's Hospital of Los Angeles), Charles G. Eberhart(Johns Hopkins University), Pooja Panwalkar(University of Michigan), Allison R. Hanaford(Johns Hopkins Medicine), Robert Doherty(University of Michigan), Deepak Nagrath(University of Michigan), Sophia Y. Lunt(Michigan State University), Alexander R. Judkins(University of Southern California), Yatrik M. Shah(University of Michigan), Paul A. Northcott(St. Jude Children's Research Hospital), Sebastian M. Waszak(European Molecular Biology Laboratory), Eric H. Raabe(Johns Hopkins University), John McKolay(University of Michigan), Abhinav Achreja(University of Michigan), Andrea Franson(Michigan Medicine), Stefan R. Sweha, Olamide Animasahun(University of Michigan), Debra Hawes(Children's Hospital of Los Angeles), Siva Kumar Natarajan(University of Michigan), Costas A. Lyssiotis(University of Michigan), Brandon Chen(University of Michigan), John R. Prensner(University of Michigan), Fusheng Yang(Children's Hospital of Los Angeles), Kyle Smith(St. Jude Children's Research Hospital), Carl Koschmann(University of Michigan), Diya Patel(University of Michigan), Martin P. Ogrodzinski(Michigan State University)
Cited by 0
Related Papers
Signatures of mutational processes in human cancer
|Nature|2013|10.1k
The landscape of somatic copy-number alteration across human cancers
|Nature|2010|4.1k
Oncogenic Kras Maintains Pancreatic Tumors through Regulation of Anabolic Glucose Metabolism
|Cell|2012|2k
Medulloblastoma Comprises Four Distinct Molecular Variants
|Journal of Clinical Oncology|2010|1.4k
Intertumoral Heterogeneity within Medulloblastoma Subgroups
|Cancer Cell|2017|1.3k